Viewing Study NCT03964532


Ignite Creation Date: 2025-12-24 @ 9:55 PM
Ignite Modification Date: 2026-02-03 @ 5:38 AM
Study NCT ID: NCT03964532
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-21
First Post: 2019-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer
Sponsor: Georgetown University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None Advanced Breast Cancer View
None Talazoparib View
None Avelumab View